10 Questions Fertility Clinic CEOs Should Ask Their Marketing Agency
Fertility clinic CEOs should evaluate marketing agency performance by shifting the focus from surface metrics like traffic and lead volume to the actual movement of patients through the treatment funnel. A high quality agency partner must be able to demonstrate how specific marketing sources convert into booked and attended consultations while identifying exactly where potential patients drop off before starting care.
You're sitting in the monthly agency review. The deck opens with rankings, then traffic, then cost per lead, then lead volume, all trending up and to the right. Nobody in the room can tell you whether any of it became a patient who started treatment.
That gap is the point of this article. Many agency meetings review marketing activity, not patient movement, and the two are easy to confuse when the slides look busy, and the arrows point the right way.
What follows is a question set you can bring to your next review. It's built to show how demand becomes patient movement, where that movement stops, and what proof is missing. Use it to decide whether your current partner is worth keeping, coaching, or replacing.
Key Takeaways
- Activity is not movement - Rankings, traffic, CPL, and lead volume can all rise while booked and attended consults stay flat.
- Ask one reframing question - Can you show how demand becomes patient movement, where it stops, and what proof is missing?
- Use 10 categories - They turn a vague agency chat into a structured patient-movement review with at least 25 concrete questions.
- Watch for shallow reporting - No CPA definition, no booked-versus-attended split, and phone calls ignored are the clearest warning signs.
- Don't fire by default - Much of the shortfall is missing measurement, so define the data and proof gaps first, then set a review date.
- A Revenue Leak Map raises the standard - It connects marketing source to consult movement and exposes where demand stops.
Why Most Agency Review Meetings Start With the Wrong Numbers
Surface metrics dominate agency decks because they're easy to produce and they always show motion. Impressions, clicks, and lead counts move every month, even when none of that motion reaches a patient.
Each of these numbers falls short on its own:
- Rankings - A position on a results page is not a citation in an AI answer or a booked consult.
- Traffic - More visitors is not the same as more qualified demand for your service lines.
- CPL - A low cost per lead can hide poor source quality and a wave of no-shows.
- Lead volume - A big lead count masks drop-off between inquiry and treatment start.
Fertility makes this gap expensive. Research cycles are long, patient value is high, and the distance between a lead and a treatment start is where the money is won or lost. The problem here is the reporting standard, not agencies as a category. A good fertility clinic marketing agency can meet a higher bar when you ask for it.
The Question a CEO Should Ask Instead
Can you show how demand becomes patient movement, where it stops, and what proof is missing?
Patient movement means the full path, measured by source: leads, contacted, booked, attended, no-show, lost, and treatment or service start. When you can see each stage by channel, you can find the exact point where interested people stop moving toward care.
Proof boundaries are the honest limits of the report. That means naming what data is missing, which metric is not yet trustworthy, and what should be fixed before you spend another dollar. The rest of this article turns that single question into a usable toolkit.
The 10 Question Categories to Structure Your Next Review
These 10 categories turn a loose agency conversation into a structured patient-movement review. Bring the table below and work down it.
The Questions to Ask, Category by Category
Scan to the area you care about. Each question is a plain sentence you can read aloud, with a note on what a strong answer sounds like.
Strategy and Patient Journey
- Which patient questions are we trying to become the answer for in Google and AI search?
- Which service lines and locations are driving qualified movement, not just traffic?
- How does your plan map to the full journey from first research to treatment start? A good answer names stages and the metric attached to each.
SEO, AI Search, and Source Quality
Search visibility now includes AI answers, so rankings alone undersell the picture. Google itself notes that the best practices for SEO remain relevant for AI features, and there are no additional requirements to appear in AI Overviews or AI Mode, nor other special optimizations necessary. AI Overviews already show up for a large share of searches, appearing for 59% of searches with informational intent and for 19% of searches with commercial intent, per Botify's analysis.
- How are you measuring AI visibility, not only rankings, and can you show a query set with screenshots?
- Which content hubs are citation-ready, and which are thin?
- Which paid and organic source has the best patients per 100 leads? Price per lead is not the same as patients per lead.
Website Conversion and Intake Follow-Up
- What happens after the CTA click?
- Does the booking or scheduler path preserve source, route, treatment interest, and patient reason?
- Do phone, form, scheduler, and chat feed the same status model? If phone leads live in a separate spreadsheet, your fertility clinic marketing agency is reporting on half your demand.
- What is our time to first response, and how is follow-up segmented by patient reason and status?
Data, Attribution, CAC, CPA, and ROI
- Can you show leads, contacted, booked, attended, no-show, lost, and treatment-start movement by source?
- How do you define CPA, and does it mean lead, appointment, attended consult, or patient?
- What data is missing from the report, and what metric should we not trust yet?
- How do you connect spend to treatment starts without treating same-month leads and same-month starts as the same cohort? Fertility timelines rarely fit inside one reporting month.
Recovery, Reporting, and Privacy
- Which lost reasons are increasing?
- Which no-show or attended-not-started patients should be recovered?
- What should we fix before increasing spend?
- How does the reporting cadence tie to a clear next decision each month?
- How do you protect patient privacy and compliance across tracking and follow-up? HHS guidance is direct that regulated entities may not impermissibly disclose PHI to tracking technology vendors, so ask how tracking is configured. See the HHS Office for Civil Rights bulletin for the standard.
Warning Signs Your Agency Report Is Too Shallow
Run this checklist against the last report you received. The more boxes you tick, the shallower the reporting.
- The report shows only impressions, clicks, leads, and CPL.
- The agency cannot define CPA.
- It cannot separate booked from attended consults.
- It ignores phone calls.
- It cannot explain source quality beyond lead price.
- It treats all service lines the same.
- It cannot show data-confidence gaps.
- It recommends more spend before auditing conversion and follow-up.
- It talks about AI search without a query set, screenshots, or content plan.
- It never asks for downstream status data.
These are gaps to close, not automatic grounds to fire.
What a Strong Agency or Partner Should Be Able to Show
Hold your partner to a clear standard. A capable one should be able to put the following on the table:
- A patient journey model that names every stage.
- A service-line keyword and content architecture, not one generic blog.
- An AI visibility query set with screenshots.
- Channel-specific source quality, measured in patients per 100 leads.
- Website conversion recommendations tied to patient intent.
- Call and form coverage in one status model.
- Lead-to-consult movement by source.
- Clear CAC and CPA definitions.
- Honest data limitations.
- A short list of next decisions.
A strong partner welcomes better downstream data instead of resisting it. If richer status data makes the numbers look worse before they look better, that's a sign the reporting is finally honest.
What to Do If Your Agency Cannot Answer Yet
Don't fire by default. Much of the shortfall is missing measurement, not bad intent, and switching vendors rarely fixes a data problem you haven't defined.
Work the gaps in a short sequence:
- Name the metrics you lack, starting with attended consults and treatment starts by source.
- Agree on how to capture phone, scheduler, and status data in one place.
- Set a date to review the closed gaps.
This is also where a neutral diagnostic earns its keep, because it shows both sides the same picture at once.
How a Revenue Leak Map Changes the Conversation
A Revenue Leak Map reveals what the current agency report misses by connecting marketing source to consult movement and exposing where demand stops. Instead of debating rankings, you look at one view of where interested patients fall out.
This is where Irresist fits. Irresist helps IVF clinics turn existing website traffic into more booked consults, preserves patient reason before the form, phone, scheduler, or chat action, tracks forms, calls, and key actions, and separates proof from estimates. It's a complement and diagnostic layer, not an agency replacement, and it makes no ROI or compliance guarantees.
The goal is to raise the standard of your next agency meeting, not to swap vendors by reflex.
What to Do Next
Bring the 10-category table and the warning-signs checklist to your next review, and open with the reframing question about patient movement and proof boundaries. If the answers stop at rankings, traffic, and CPL, you've found your first gap to close, not your reason to fire.
From there, request a Revenue Leak Map from Irresist to turn that meeting from a traffic review into a patient-movement review, then set a follow-up date to check the numbers you fix.
FAQ
What should an IVF clinic CEO ask a marketing agency?
Start with the reframe: can you show how demand becomes patient movement, where it stops, and what proof is missing? The three highest-value follow-ups cover strategy (does the plan map the full journey to treatment start?), source quality (which source has the best patients per 100 leads?), and attribution (how do you define CPA and connect spend to treatment starts?).
How do I know if our fertility marketing agency is reporting the right metrics?
Run the warning-signs checklist against your last report. The clearest tell is whether the agency can split booked consults from attended consults and include phone calls in the same status model. Reporting that stops at impressions, clicks, leads, and CPL is too shallow to guide spend.
What is the difference between CPL and CPA in fertility marketing?
CPL, cost per lead, stops at the inquiry and says nothing about quality or attendance. CPA, cost per acquisition, only means something once it's defined, so insist the agency name whether it counts a lead, an appointment, an attended consult, or a patient who started treatment.
Should we fire an agency that cannot show patient movement?
Not by default. Much of the shortfall is missing measurement rather than bad intent, so define the missing data and proof gaps together first. Name the metrics you lack, agree on how to capture phone and status data, and set a date to review the closed gaps before making a personnel decision.
How should a fertility clinic evaluate an SEO or AI-search agency?
Ask for a real query set with screenshots, a view of AI visibility that goes beyond rankings, and a clear map of which content hubs are citation-ready versus thin. Because AI Overviews pull from pages that already rank well, a credible fertility clinic SEO agency ties AI readiness to strong underlying content and structure.
What is a Revenue Leak Map?
A Revenue Leak Map is a diagnostic that connects marketing source to consult movement and reveals where demand stops on the way to a booked and attended consult. It shows what the current agency report misses without making ROI or compliance guarantees, so your next review focuses on patient movement rather than traffic.
